Pneumococcal Infections research hub

C4801002 - A Phase 2, Randomized, Open-Label Trial to Describe the Safety and Immunogenicity of A Monovalent Pneumococcal Conjugate Candidate Administered As a 2-Dose Series in Healthy Toddlers 12 Through 15 Months of Age Who Previously Received PCV10 Primary Series in the European Union

This study is looking at a new pneumonia vaccine for toddlers aged 12 to 15 months in the EU. It checks how safe the vaccine is and how well it helps their bodies fight off infections. All toddlers in the study have already had a different pneumonia vaccine.